Shopping Cart 0
Cart Subtotal
AED 0

Genito-Urinary Drugs MGR 2017

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 14680

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 14680

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 22020

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
AED 14680

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 29360

Details

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases.

Some of the major drugs in the market include Avastin, Trimethoprim/sulfamethoxazole, Fosfomycin, Nitrofurantoin, Ciprofloxacin, Sildinafil, Levofloxacin, Cephalexin, Ceftriaxone, and Azithromycin.

The global genito-urinary drugs market was estimated to be around $60 billion as of 2016. The genito-urinary drugs market made up around 5.5% of the overall pharmaceuticals market in 2016. The genito-urinary drugs market was the nineth largest market in the global pharmaceutical market in 2016.

New Of Combination Products

Launch of combination products for the treatment of urinary tract infections is an emerging trend in the genitourinary disorders drugs market. Competitors are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genitourinary disorder drugs. For instance, Merck Sharp & Dohme Corp. offers ZERBAXA, a combination drug of a novel cephalosporin and a beta-lactamase inhibitor used for the treatment of complicated urinary tract infections.

The Genito-Urinary Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the genito-urinary drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genito-urinary drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The genito-urinary drugs market section of the report gives context. It compares the genito-urinary drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Genito-Urinary Drugs Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Hormonal Contraceptives, Benign Prostatic Hypertrophy, Infertility, Erectile Dysfunction, Urinary Incontinence And Overactive Bladder, Infections And Others, Harmonal Replacement Therapy, Diuretics

Companies Mentioned: Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Bayer AG

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Genito-Urinary Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

READ MORE

Table Of Content

Scope

1. Genito-Urinary Drugs Market Characteristics;

2. Genito-Urinary Drugs Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Genito-Urinary Drugs Market Customer Information;

5. Genito-Urinary Drugs Market Segmentation;

5.1. Global Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 5.2. Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Genito-Urinary Drugs Market Trends And Strategies;

6. Genito-Urinary Drugs Market Regional And Country Analysis;

6.1. Global Genito-Urinary Drugs Market, 2016, By Region; 6.2. Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Genito-Urinary Drugs Market, 2016, By Country; 6.4. Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Genito-Urinary Drugs Market Comparison With Macro Economic Factors;

7.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Genito-Urinary Drugs Expenditure, Global;

8. Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries;

8.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Genito-Urinary Drugs Expenditure, By Country;

9. Genito-Urinary Drugs Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Contraceptives, 2015, By Country; 9.10. Global Number Of Obstetricians And Gynaecologists 2016, By Country; 9.11. Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country; 9.12. Global Number Of General Practitioners 2016, By Country; 9.13. Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Genito-Urinary Drugs Market;

10.1.1. Asia-Pacific Genito-Urinary Drugs Market Overview; 10.1.2. Asia-Pacific Genito-Urinary Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.2. Asia-Pacific Genito-Urinary Drugs Market: Country Analysis; 10.3. China Genito-Urinary Drugs Market; 10.3.1. China Genito-Urinary Drugs Market Overview; 10.3.2. China Genito-Urinary Drugs Historic Market, 2012-2016; 10.3.3. China Genito-Urinary Drugs Forecast Market, 2016-2020; 10.3.4. China Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.3.5. China Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 10.4. India Genito-Urinary Drugs Market; 10.4.1. India Genito-Urinary Drugs Market Overview; 10.4.2. India Genito-Urinary Drugs Historic Market, 2012-2016; 10.4.3. India Genito-Urinary Drugs Forecast Market, 2016-2020; 10.4.4. India Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.4.5. India Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 10.5. Japan Genito-Urinary Drugs Market; 10.5.1. Japan Genito-Urinary Drugs Market Overview; 10.5.2. Japan Genito-Urinary Drugs Historic Market, 2012-2016; 10.5.3. Japan Genito-Urinary Drugs Forecast Market, 2016-2020; 10.5.4. Japan Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.5.5. Japan Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 10.6. Australia Genito-Urinary Drugs Market; 10.6.1. Australia Genito-Urinary Drugs Historic Market, 2012-2016; 10.6.2. Australia Genito-Urinary Drugs Forecast Market, 2016-2020; 10.6.3. Australia Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.6.4. Australia Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

11. Western Europe Genito-Urinary Drugs Market;

11.1.1. Western Europe Genito-Urinary Drugs Market Overview; 11.1.2. Western Europe Genito-Urinary Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Genito-Urinary Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.2. Western Europe Genito-Urinary Drugs Market: Country Analysis; 11.3. UK Genito-Urinary Drugs Market; 11.3.1. UK Genito-Urinary Drugs Market Overview; 11.3.2. UK Genito-Urinary Drugs Historic Market, 2012-2016; 11.3.3. UK Genito-Urinary Drugs Forecast Market, 2016-2020; 11.3.4. UK Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.3.5. UK Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.4. Germany Genito-Urinary Drugs Market; 11.4.1. Germany Genito-Urinary Drugs Historic Market, 2012-2016; 11.4.2. Germany Genito-Urinary Drugs Forecast Market, 2016-2020; 11.4.3. Germany Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.4.4 Germany Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.5 France Genito-Urinary Drugs Market; 11.5.1 France Genito-Urinary Drugs Historic Market, 2012-2016; 11.5.2 France Genito-Urinary Drugs Forecast Market, 2016-2020; 11.5.3 France Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.5.4 France Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.6. Italy Genito-Urinary Drugs Market; 11.6.1. Italy Genito-Urinary Drugs Historic Market, 2012-2016; 11.6.2. Italy Genito-Urinary Drugs Forecast Market, 2016-2020; 11.6.3. Italy Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.6.4. Italy Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.7. Spain Genito-Urinary Drugs Market; 11.7.1. Spain Genito-Urinary Drugs Historic Market, 2012-2016; 11.7.2. Spain Genito-Urinary Drugs Forecast Market, 2016-2020; 11.7.3. Spain Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 11.7.4. Spain Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

12. Eastern Europe Genito-Urinary Drugs Market;

12.1.1. Eastern Europe Genito-Urinary Drugs Market Overview; 12.1.2. Eastern Europe Genito-Urinary Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Genito-Urinary Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 12.2. Eastern Europe Genito-Urinary Drugs Market: Country Analysis; 12.3. Russia Genito-Urinary Drugs Market; 12.3.1. Russia Genito-Urinary Drugs Historic Market, 2012-2016; 12.3.2. Russia Genito-Urinary Drugs Forecast Market, 2016-2020; 12.3.3. Russia Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 12.3.4. Russia Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

13. North America Genito-Urinary Drugs Market;

13.1.1. North America Genito-Urinary Drugs Market Overview; 13.1.2. North America Genito-Urinary Drugs Historic Market, 2012-2016; 13.1.3. North America Genito-Urinary Drugs Forecast Market, 2016-2020; 13.1.4. North America Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 13.2. North America Genito-Urinary Drugs Market: Country Analysis; 13.3. USA Genito-Urinary Drugs Market; 13.3.1. USA Genito-Urinary Drugs Historic Market, 2012-2016; 13.3.2. USA Genito-Urinary Drugs Forecast Market, 2016-2020; 13.3.3 USA Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 13.3.4. USA Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

14. South America Genito-Urinary Drugs Market;

14.1.1. South America Genito-Urinary Drugs Market Overview; 14.1.2. South America Genito-Urinary Drugs Historic Market, 2012-2016; 14.1.3. South America Genito-Urinary Drugs Forecast Market, 2016-2020; 14.1.4. South America Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 14.2. South America Genito-Urinary Drugs Market: Country Analysis; 14.3. Brazil Genito-Urinary Drugs Market; 14.3.1. Brazil Genito-Urinary Drugs Historic Market, 2012-2016; 14.3.2. Brazil Genito-Urinary Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 14.3.4. Brazil Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

15. Middle East Genito-Urinary Drugs Market;

15.1.1. Middle East Genito-Urinary Drugs Market Overview; 15.1.1. Middle East Genito-Urinary Drugs Market Overview; 15.1.2. Middle East Genito-Urinary Drugs Historic Market, 2012-2016; 15.1.3. Middle East Genito-Urinary Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ;

16. Africa Genito-Urinary Drugs Market;

16.1.1. Africa Genito-Urinary Drugs Market Overview; 16.1.2. Africa Genito-Urinary Drugs Historic Market, 2012-2016; 16.1.3. Africa Genito-Urinary Drugs Forecast Market, 2016-2020; 16.1.4. Africa Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;

17. Genito-Urinary Drugs Market Competitive Landscape;

17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bristol-Myers Squibb Company; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbott Laboratories; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Bayer Ag; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;

19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer


List Of Figure

Table 1: Global Genito-Urinary Drugs Historic Market Growth

Table 2: Global Genito-Urinary Drugs Forecast Market Growth

Table 3: Genito-Urinary Drugs Market Segmentation

Table 4: Global Genito-Urinary Drugs Market, 2016, By Segment

Table 5: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Genito-Urinary Drugs Market, 2016, By Region

Table 7: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 8: Genito-Urinary Drugs Market, 2016, By Country

Table 9: Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 10: Global Pharmaceutical Market Segments, 2016, By Region

Table 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 12: Global Pharmaceutical Market Segments, 2016, By Country

Table 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 14: Genito-Urinary Drugs Market Size, Percentage Of GDP, Global

Table 15: Per Capita Average Genito-Urinary Drugs Expenditure, Global

Table 16: Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries

Table 17: Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country

Table 18: Per Capita Average Genito-Urinary Drugs Expenditure, By Country

Table 19: Global Number Of Pharmacists, 2016, By Country

Table 20: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 21: Global Number Of Pharma Enterprises, 2016, By Country

Table 22: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 23: Global Average Spending On R&D/Product Development, 2016, By Country

Table 24: Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 26: Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 27: Prevalent Cases Of Contraceptives, 2015, By Country

Table 28: Global Number Of Obstetricians And Gynaecologists 2016, By Country

Table 29: Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country

Table 30: Global Number Of General Practitioners 2016, By Country

Table 31: Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Table 32: Asia-Pacific Genito-Urinary Drugs Historic Market, 2012-2016

Table 33: Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016-2020

Table 34: Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment

Table 35: China Genito-Urinary Drugs Historic Market, 2012-2016

Table 36: China Genito-Urinary Drugs Forecast Market, 2016-2020

Table 37: China Genito-Urinary Drugs Market, 2016, By Segment

Table 38: China Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 39: China Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 40: India Genito-Urinary Drugs Historic Market, 2012-2016

Table 41: India Genito-Urinary Drugs Forecast Market, 2016-2020

Table 42: India Genito-Urinary Drugs Market, 2016, By Segment

Table 43: India Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 44: India Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 45: Japan Genito-Urinary Drugs Historic Market, 2012-2016

Table 46: Japan Genito-Urinary Drugs Forecast Market, 2016-2020

Table 47: Japan Genito-Urinary Drugs Market, 2016, By Segment

Table 48: Japan Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 49: Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 50: Australia Genito-Urinary Drugs Historic Market, 2012-2016

Table 51: Australia Genito-Urinary Drugs Forecast Market, 2016-2020

Table 52: Australia Genito-Urinary Drugs Market, 2016, By Segment

Table 53: Australia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 54: Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 55: Western Europe Genito-Urinary Drugs Historic Market, 2012-2016

Table 56: Western Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Table 57: Western Europe Genito-Urinary Drugs Market, 2016, By Segment

Table 58: UK Genito-Urinary Drugs Historic Market, 2012-2016

Table 59: UK Genito-Urinary Drugs Forecast Market, 2016-2020

Table 60: UK Genito-Urinary Drugs Market, 2016, By Segment

Table 61: UK Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 62: UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 63: Germany Genito-Urinary Drugs Historic Market, 2012-2016

Table 64: Germany Genito-Urinary Drugs Forecast Market, 2016-2020

Table 65: Germany Genito-Urinary Drugs Market, 2016, By Segment

Table 66: Germany Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 67: Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 68: France Genito-Urinary Drugs Historic Market, 2012-2016

Table 69: France Genito-Urinary Drugs Forecast Market, 2016-2020

Table 70: France Genito-Urinary Drugs Market, 2016, By Segment

Table 71: France Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 72: France Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 73: Italy Genito-Urinary Drugs Historic Market, 2012-2016

Table 74: Italy Genito-Urinary Drugs Forecast Market, 2016-2020

Table 75: Italy Genito-Urinary Drugs Market, 2016, By Segment

Table 76: Italy Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 77: Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 78: Spain Genito-Urinary Drugs Historic Market, 2012-2016

Table 79: Spain Genito-Urinary Drugs Forecast Market, 2016-2020

Table 80: Spain Genito-Urinary Drugs Market, 2016, By Segment

Table 81: Spain Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 82: Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 83: Eastern Europe Genito-Urinary Drugs Historic Market, 2012-2016

Table 84: Eastern Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Table 85: Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment

Table 86: Russia Genito-Urinary Drugs Historic Market, 2012-2016

Table 87: Russia Genito-Urinary Drugs Forecast Market, 2016-2020

Table 88: Russia Genito-Urinary Drugs Market, 2016, By Segment

Table 89: Russia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 90: Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 91: North America Genito-Urinary Drugs Historic Market, 2012-2016

Table 92: North America Genito-Urinary Drugs Forecast Market, 2016-2020

Table 93: North America Genito-Urinary Drugs Market, 2016, By Segment

Table 94: USA Genito-Urinary Drugs Historic Market, 2012-2016

Table 95: USA Genito-Urinary Drugs Forecast Market, 2016-2020

Table 96: USA Genito-Urinary Drugs Market, 2016, By Segment

Table 97: USA Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 98: USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 99: South America Genito-Urinary Drugs Historic Market, 2012-2016

Table 100: South America Genito-Urinary Drugs Forecast Market, 2016-2020

Table 101: South America Genito-Urinary Drugs Market, 2016, By Segment

Table 102: Brazil Genito-Urinary Drugs Historic Market, 2012-2016

Table 103: Brazil Genito-Urinary Drugs Forecast Market, 2016-2020

Table 104: Brazil Genito-Urinary Drugs Market, 2016, By Segment

Table 105: Brazil Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 106: Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 107: Middle East Genito-Urinary Drugs Historic Market, 2012-2016

Table 108: Middle East Genito-Urinary Drugs Forecast Market, 2016-2020

Table 109: Middle East Genito-Urinary Drugs Market, 2016, By Segment

Table 110: Africa Genito-Urinary Drugs Historic Market, 2012-2016

Table 111: Africa Genito-Urinary Drugs Forecast Market, 2016-2020

Table 112: Africa Genito-Urinary Drugs Market, 2016, By Segment

Table 113: Pfizer Inc. Financial Performance

Table 114: Bristol-Myers Squibb Company Financial Performance

Table 115: F. Hoffmann-La Roche Ltd Financial Performance

Table 116: Abbott Laboratories Financial Performance

Table 117: Bayer Ag Financial Performance

Table 118: Pharmaceutical Drugs Market Historic Growth

Table 119: Pharmaceutical Drugs Market Forecast Growth

Table 120: Global Pharmaceutical Drugs Market, 2016, By Region

Table 121: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 122: Pharmaceutical Drugs Market, 2016, By Country

Table 123: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 124: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Table 125: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Table 126: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 127: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 128: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 129: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 130: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 131: Pharmaceuticals Industry Financial Margins


List Of Table

Figure 1: Global Genito-Urinary Drugs Historic Market Growth

Figure 2: Global Genito-Urinary Drugs Forecast Market Growth

Figure 3: Genito-Urinary Drugs Market Segmentation

Figure 4: Global Genito-Urinary Drugs Market, 2016, By Segment

Figure 5: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Genito-Urinary Drugs Market, 2016, By Region

Figure 7: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 8: Genito-Urinary Drugs Market, 2016, By Country

Figure 9: Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 10: Global Pharmaceutical Market Segments, 2016, By Region

Figure 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 12: Global Pharmaceutical Market Segments, 2016, By Country

Figure 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 14: Genito-Urinary Drugs Market Size, Percentage Of GDP, Global

Figure 15: Per Capita Average Genito-Urinary Drugs Expenditure, Global

Figure 16: Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 17: Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country

Figure 18: Per Capita Average Genito-Urinary Drugs Expenditure, By Country

Figure 19: Global Number Of Pharmacists, 2016, By Country

Figure 20: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 21: Global Number Of Pharma Enterprises, 2016, By Country

Figure 22: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 23: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 24: Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 26: Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 27: Prevalent Cases Of Contraceptives, 2015, By Country

Figure 28: Global Number Of Obstetricians And Gynaecologists 2016, By Country

Figure 29: Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country

Figure 30: Global Number Of General Practitioners 2016, By Country

Figure 31: Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Figure 32: Asia-Pacific Genito-Urinary Drugs Historic Market, 2012-2016

Figure 33: Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 34: Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment

Figure 35: China Genito-Urinary Drugs Historic Market, 2012-2016

Figure 36: China Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 37: China Genito-Urinary Drugs Market, 2016, By Segment

Figure 38: China Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 39: China Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 40: India Genito-Urinary Drugs Historic Market, 2012-2016

Figure 41: India Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 42: India Genito-Urinary Drugs Market, 2016, By Segment

Figure 43: India Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 44: India Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 45: Japan Genito-Urinary Drugs Historic Market, 2012-2016

Figure 46: Japan Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 47: Japan Genito-Urinary Drugs Market, 2016, By Segment

Figure 48: Japan Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 49: Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 50: Australia Genito-Urinary Drugs Historic Market, 2012-2016

Figure 51: Australia Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 52: Australia Genito-Urinary Drugs Market, 2016, By Segment

Figure 53: Australia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 54: Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 55: Western Europe Genito-Urinary Drugs Historic Market, 2012-2016

Figure 56: Western Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 57: Western Europe Genito-Urinary Drugs Market, 2016, By Segment

Figure 58: UK Genito-Urinary Drugs Historic Market, 2012-2016

Figure 59: UK Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 60: UK Genito-Urinary Drugs Market, 2016, By Segment

Figure 61: UK Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 62: UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 63: Germany Genito-Urinary Drugs Historic Market, 2012-2016

Figure 64: Germany Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 65: Germany Genito-Urinary Drugs Market, 2016, By Segment

Figure 66: Germany Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 67: Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 68: France Genito-Urinary Drugs Historic Market, 2012-2016

Figure 69: France Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 70: France Genito-Urinary Drugs Market, 2016, By Segment

Figure 71: France Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 72: France Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 73: Italy Genito-Urinary Drugs Historic Market, 2012-2016

Figure 74: Italy Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 75: Italy Genito-Urinary Drugs Market, 2016, By Segment

Figure 76: Italy Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 77: Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 78: Spain Genito-Urinary Drugs Historic Market, 2012-2016

Figure 79: Spain Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 80: Spain Genito-Urinary Drugs Market, 2016, By Segment

Figure 81: Spain Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 82: Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 83: Eastern Europe Genito-Urinary Drugs Historic Market, 2012-2016

Figure 84: Eastern Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 85: Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment

Figure 86: Russia Genito-Urinary Drugs Historic Market, 2012-2016

Figure 87: Russia Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 88: Russia Genito-Urinary Drugs Market, 2016, By Segment

Figure 89: Russia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 90: Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 91: North America Genito-Urinary Drugs Historic Market, 2012-2016

Figure 92: North America Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 93: North America Genito-Urinary Drugs Market, 2016, By Segment

Figure 94: USA Genito-Urinary Drugs Historic Market, 2012-2016

Figure 95: USA Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 96: USA Genito-Urinary Drugs Market, 2016, By Segment

Figure 97: USA Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 98: USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 99: South America Genito-Urinary Drugs Historic Market, 2012-2016

Figure 100: South America Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 101: South America Genito-Urinary Drugs Market, 2016, By Segment

Figure 102: Brazil Genito-Urinary Drugs Historic Market, 2012-2016

Figure 103: Brazil Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 104: Brazil Genito-Urinary Drugs Market, 2016, By Segment

Figure 105: Brazil Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 106: Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 107: Middle East Genito-Urinary Drugs Historic Market, 2012-2016

Figure 108: Middle East Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 109: Middle East Genito-Urinary Drugs Market, 2016, By Segment

Figure 110: Africa Genito-Urinary Drugs Historic Market, 2012-2016

Figure 111: Africa Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 112: Africa Genito-Urinary Drugs Market, 2016, By Segment

Figure 113: Pfizer Inc. Financial Performance

Figure 114: Bristol-Myers Squibb Company Financial Performance

Figure 115: F. Hoffmann-La Roche Ltd Financial Performance

Figure 116: Abbott Laboratories Financial Performance

Figure 117: Bayer Ag Financial Performance

Figure 118: Pharmaceutical Drugs Market Historic Growth

Figure 119: Pharmaceutical Drugs Market Forecast Growth

Figure 120: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 121: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 122: Pharmaceutical Drugs Market, 2016, By Country

Figure 123: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 124: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Figure 125: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Figure 126: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 127: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 128: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 129: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 130: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 131: Pharmaceuticals Industry Financial Margins

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Hormonal Contraceptives, Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Harmonal Replacement Therapy, Diuretics


Companies

Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Bayer AG

Company Profile

Company Profile Title

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases.

Some of the major drugs in the market include Avastin, Trimethoprim/sulfamethoxazole, Fosfomycin, Nitrofurantoin, Ciprofloxacin, Sildinafil, Levofloxacin, Cephalexin, Ceftriaxone, and Azithromycin.

The global genito-urinary drugs market was estimated to be around $60 billion as of 2016. The genito-urinary drugs market made up around 5.5% of the overall pharmaceuticals market in 2016. The genito-urinary drugs market was the nineth largest market in the global pharmaceutical market in 2016.

New Of Combination Products

Launch of combination products for the treatment of urinary tract infections is an emerging trend in the genitourinary disorders drugs market. Competitors are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genitourinary disorder drugs. For instance, Merck Sharp & Dohme Corp. offers ZERBAXA, a combination drug of a novel cephalosporin and a beta-lactamase inhibitor used for the treatment of complicated urinary tract infections.

The Genito-Urinary Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the genito-urinary drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genito-urinary drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The genito-urinary drugs market section of the report gives context. It compares the genito-urinary drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Genito-Urinary Drugs Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Hormonal Contraceptives, Benign Prostatic Hypertrophy, Infertility, Erectile Dysfunction, Urinary Incontinence And Overactive Bladder, Infections And Others, Harmonal Replacement Therapy, Diuretics

Companies Mentioned: Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Bayer AG

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Genito-Urinary Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

READ MORE

Scope

1. Genito-Urinary Drugs Market Characteristics;

2. Genito-Urinary Drugs Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Genito-Urinary Drugs Market Customer Information;

5. Genito-Urinary Drugs Market Segmentation;

5.1. Global Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 5.2. Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Genito-Urinary Drugs Market Trends And Strategies;

6. Genito-Urinary Drugs Market Regional And Country Analysis;

6.1. Global Genito-Urinary Drugs Market, 2016, By Region; 6.2. Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Genito-Urinary Drugs Market, 2016, By Country; 6.4. Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Genito-Urinary Drugs Market Comparison With Macro Economic Factors;

7.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Genito-Urinary Drugs Expenditure, Global;

8. Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries;

8.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Genito-Urinary Drugs Expenditure, By Country;

9. Genito-Urinary Drugs Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Contraceptives, 2015, By Country; 9.10. Global Number Of Obstetricians And Gynaecologists 2016, By Country; 9.11. Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country; 9.12. Global Number Of General Practitioners 2016, By Country; 9.13. Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Genito-Urinary Drugs Market;

10.1.1. Asia-Pacific Genito-Urinary Drugs Market Overview; 10.1.2. Asia-Pacific Genito-Urinary Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.2. Asia-Pacific Genito-Urinary Drugs Market: Country Analysis; 10.3. China Genito-Urinary Drugs Market; 10.3.1. China Genito-Urinary Drugs Market Overview; 10.3.2. China Genito-Urinary Drugs Historic Market, 2012-2016; 10.3.3. China Genito-Urinary Drugs Forecast Market, 2016-2020; 10.3.4. China Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.3.5. China Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 10.4. India Genito-Urinary Drugs Market; 10.4.1. India Genito-Urinary Drugs Market Overview; 10.4.2. India Genito-Urinary Drugs Historic Market, 2012-2016; 10.4.3. India Genito-Urinary Drugs Forecast Market, 2016-2020; 10.4.4. India Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.4.5. India Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 10.5. Japan Genito-Urinary Drugs Market; 10.5.1. Japan Genito-Urinary Drugs Market Overview; 10.5.2. Japan Genito-Urinary Drugs Historic Market, 2012-2016; 10.5.3. Japan Genito-Urinary Drugs Forecast Market, 2016-2020; 10.5.4. Japan Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.5.5. Japan Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 10.6. Australia Genito-Urinary Drugs Market; 10.6.1. Australia Genito-Urinary Drugs Historic Market, 2012-2016; 10.6.2. Australia Genito-Urinary Drugs Forecast Market, 2016-2020; 10.6.3. Australia Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.6.4. Australia Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

11. Western Europe Genito-Urinary Drugs Market;

11.1.1. Western Europe Genito-Urinary Drugs Market Overview; 11.1.2. Western Europe Genito-Urinary Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Genito-Urinary Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.2. Western Europe Genito-Urinary Drugs Market: Country Analysis; 11.3. UK Genito-Urinary Drugs Market; 11.3.1. UK Genito-Urinary Drugs Market Overview; 11.3.2. UK Genito-Urinary Drugs Historic Market, 2012-2016; 11.3.3. UK Genito-Urinary Drugs Forecast Market, 2016-2020; 11.3.4. UK Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.3.5. UK Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.4. Germany Genito-Urinary Drugs Market; 11.4.1. Germany Genito-Urinary Drugs Historic Market, 2012-2016; 11.4.2. Germany Genito-Urinary Drugs Forecast Market, 2016-2020; 11.4.3. Germany Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.4.4 Germany Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.5 France Genito-Urinary Drugs Market; 11.5.1 France Genito-Urinary Drugs Historic Market, 2012-2016; 11.5.2 France Genito-Urinary Drugs Forecast Market, 2016-2020; 11.5.3 France Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.5.4 France Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.6. Italy Genito-Urinary Drugs Market; 11.6.1. Italy Genito-Urinary Drugs Historic Market, 2012-2016; 11.6.2. Italy Genito-Urinary Drugs Forecast Market, 2016-2020; 11.6.3. Italy Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.6.4. Italy Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020; 11.7. Spain Genito-Urinary Drugs Market; 11.7.1. Spain Genito-Urinary Drugs Historic Market, 2012-2016; 11.7.2. Spain Genito-Urinary Drugs Forecast Market, 2016-2020; 11.7.3. Spain Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 11.7.4. Spain Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

12. Eastern Europe Genito-Urinary Drugs Market;

12.1.1. Eastern Europe Genito-Urinary Drugs Market Overview; 12.1.2. Eastern Europe Genito-Urinary Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Genito-Urinary Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 12.2. Eastern Europe Genito-Urinary Drugs Market: Country Analysis; 12.3. Russia Genito-Urinary Drugs Market; 12.3.1. Russia Genito-Urinary Drugs Historic Market, 2012-2016; 12.3.2. Russia Genito-Urinary Drugs Forecast Market, 2016-2020; 12.3.3. Russia Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 12.3.4. Russia Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

13. North America Genito-Urinary Drugs Market;

13.1.1. North America Genito-Urinary Drugs Market Overview; 13.1.2. North America Genito-Urinary Drugs Historic Market, 2012-2016; 13.1.3. North America Genito-Urinary Drugs Forecast Market, 2016-2020; 13.1.4. North America Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 13.2. North America Genito-Urinary Drugs Market: Country Analysis; 13.3. USA Genito-Urinary Drugs Market; 13.3.1. USA Genito-Urinary Drugs Historic Market, 2012-2016; 13.3.2. USA Genito-Urinary Drugs Forecast Market, 2016-2020; 13.3.3 USA Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 13.3.4. USA Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

14. South America Genito-Urinary Drugs Market;

14.1.1. South America Genito-Urinary Drugs Market Overview; 14.1.2. South America Genito-Urinary Drugs Historic Market, 2012-2016; 14.1.3. South America Genito-Urinary Drugs Forecast Market, 2016-2020; 14.1.4. South America Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 14.2. South America Genito-Urinary Drugs Market: Country Analysis; 14.3. Brazil Genito-Urinary Drugs Market; 14.3.1. Brazil Genito-Urinary Drugs Historic Market, 2012-2016; 14.3.2. Brazil Genito-Urinary Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 14.3.4. Brazil Genito-Urinary Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020;

15. Middle East Genito-Urinary Drugs Market;

15.1.1. Middle East Genito-Urinary Drugs Market Overview; 15.1.1. Middle East Genito-Urinary Drugs Market Overview; 15.1.2. Middle East Genito-Urinary Drugs Historic Market, 2012-2016; 15.1.3. Middle East Genito-Urinary Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ;

16. Africa Genito-Urinary Drugs Market;

16.1.1. Africa Genito-Urinary Drugs Market Overview; 16.1.2. Africa Genito-Urinary Drugs Historic Market, 2012-2016; 16.1.3. Africa Genito-Urinary Drugs Forecast Market, 2016-2020; 16.1.4. Africa Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;

17. Genito-Urinary Drugs Market Competitive Landscape;

17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bristol-Myers Squibb Company; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbott Laboratories; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Bayer Ag; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;

19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer


List Of Figure

Table 1: Global Genito-Urinary Drugs Historic Market Growth

Table 2: Global Genito-Urinary Drugs Forecast Market Growth

Table 3: Genito-Urinary Drugs Market Segmentation

Table 4: Global Genito-Urinary Drugs Market, 2016, By Segment

Table 5: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Genito-Urinary Drugs Market, 2016, By Region

Table 7: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 8: Genito-Urinary Drugs Market, 2016, By Country

Table 9: Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 10: Global Pharmaceutical Market Segments, 2016, By Region

Table 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 12: Global Pharmaceutical Market Segments, 2016, By Country

Table 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 14: Genito-Urinary Drugs Market Size, Percentage Of GDP, Global

Table 15: Per Capita Average Genito-Urinary Drugs Expenditure, Global

Table 16: Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries

Table 17: Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country

Table 18: Per Capita Average Genito-Urinary Drugs Expenditure, By Country

Table 19: Global Number Of Pharmacists, 2016, By Country

Table 20: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 21: Global Number Of Pharma Enterprises, 2016, By Country

Table 22: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 23: Global Average Spending On R&D/Product Development, 2016, By Country

Table 24: Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 26: Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 27: Prevalent Cases Of Contraceptives, 2015, By Country

Table 28: Global Number Of Obstetricians And Gynaecologists 2016, By Country

Table 29: Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country

Table 30: Global Number Of General Practitioners 2016, By Country

Table 31: Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Table 32: Asia-Pacific Genito-Urinary Drugs Historic Market, 2012-2016

Table 33: Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016-2020

Table 34: Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment

Table 35: China Genito-Urinary Drugs Historic Market, 2012-2016

Table 36: China Genito-Urinary Drugs Forecast Market, 2016-2020

Table 37: China Genito-Urinary Drugs Market, 2016, By Segment

Table 38: China Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 39: China Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 40: India Genito-Urinary Drugs Historic Market, 2012-2016

Table 41: India Genito-Urinary Drugs Forecast Market, 2016-2020

Table 42: India Genito-Urinary Drugs Market, 2016, By Segment

Table 43: India Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 44: India Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 45: Japan Genito-Urinary Drugs Historic Market, 2012-2016

Table 46: Japan Genito-Urinary Drugs Forecast Market, 2016-2020

Table 47: Japan Genito-Urinary Drugs Market, 2016, By Segment

Table 48: Japan Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 49: Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 50: Australia Genito-Urinary Drugs Historic Market, 2012-2016

Table 51: Australia Genito-Urinary Drugs Forecast Market, 2016-2020

Table 52: Australia Genito-Urinary Drugs Market, 2016, By Segment

Table 53: Australia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 54: Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 55: Western Europe Genito-Urinary Drugs Historic Market, 2012-2016

Table 56: Western Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Table 57: Western Europe Genito-Urinary Drugs Market, 2016, By Segment

Table 58: UK Genito-Urinary Drugs Historic Market, 2012-2016

Table 59: UK Genito-Urinary Drugs Forecast Market, 2016-2020

Table 60: UK Genito-Urinary Drugs Market, 2016, By Segment

Table 61: UK Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 62: UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 63: Germany Genito-Urinary Drugs Historic Market, 2012-2016

Table 64: Germany Genito-Urinary Drugs Forecast Market, 2016-2020

Table 65: Germany Genito-Urinary Drugs Market, 2016, By Segment

Table 66: Germany Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 67: Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 68: France Genito-Urinary Drugs Historic Market, 2012-2016

Table 69: France Genito-Urinary Drugs Forecast Market, 2016-2020

Table 70: France Genito-Urinary Drugs Market, 2016, By Segment

Table 71: France Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 72: France Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 73: Italy Genito-Urinary Drugs Historic Market, 2012-2016

Table 74: Italy Genito-Urinary Drugs Forecast Market, 2016-2020

Table 75: Italy Genito-Urinary Drugs Market, 2016, By Segment

Table 76: Italy Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 77: Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 78: Spain Genito-Urinary Drugs Historic Market, 2012-2016

Table 79: Spain Genito-Urinary Drugs Forecast Market, 2016-2020

Table 80: Spain Genito-Urinary Drugs Market, 2016, By Segment

Table 81: Spain Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 82: Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 83: Eastern Europe Genito-Urinary Drugs Historic Market, 2012-2016

Table 84: Eastern Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Table 85: Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment

Table 86: Russia Genito-Urinary Drugs Historic Market, 2012-2016

Table 87: Russia Genito-Urinary Drugs Forecast Market, 2016-2020

Table 88: Russia Genito-Urinary Drugs Market, 2016, By Segment

Table 89: Russia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 90: Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 91: North America Genito-Urinary Drugs Historic Market, 2012-2016

Table 92: North America Genito-Urinary Drugs Forecast Market, 2016-2020

Table 93: North America Genito-Urinary Drugs Market, 2016, By Segment

Table 94: USA Genito-Urinary Drugs Historic Market, 2012-2016

Table 95: USA Genito-Urinary Drugs Forecast Market, 2016-2020

Table 96: USA Genito-Urinary Drugs Market, 2016, By Segment

Table 97: USA Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 98: USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 99: South America Genito-Urinary Drugs Historic Market, 2012-2016

Table 100: South America Genito-Urinary Drugs Forecast Market, 2016-2020

Table 101: South America Genito-Urinary Drugs Market, 2016, By Segment

Table 102: Brazil Genito-Urinary Drugs Historic Market, 2012-2016

Table 103: Brazil Genito-Urinary Drugs Forecast Market, 2016-2020

Table 104: Brazil Genito-Urinary Drugs Market, 2016, By Segment

Table 105: Brazil Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Table 106: Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Table 107: Middle East Genito-Urinary Drugs Historic Market, 2012-2016

Table 108: Middle East Genito-Urinary Drugs Forecast Market, 2016-2020

Table 109: Middle East Genito-Urinary Drugs Market, 2016, By Segment

Table 110: Africa Genito-Urinary Drugs Historic Market, 2012-2016

Table 111: Africa Genito-Urinary Drugs Forecast Market, 2016-2020

Table 112: Africa Genito-Urinary Drugs Market, 2016, By Segment

Table 113: Pfizer Inc. Financial Performance

Table 114: Bristol-Myers Squibb Company Financial Performance

Table 115: F. Hoffmann-La Roche Ltd Financial Performance

Table 116: Abbott Laboratories Financial Performance

Table 117: Bayer Ag Financial Performance

Table 118: Pharmaceutical Drugs Market Historic Growth

Table 119: Pharmaceutical Drugs Market Forecast Growth

Table 120: Global Pharmaceutical Drugs Market, 2016, By Region

Table 121: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 122: Pharmaceutical Drugs Market, 2016, By Country

Table 123: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 124: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Table 125: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Table 126: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 127: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 128: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 129: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 130: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 131: Pharmaceuticals Industry Financial Margins


List Of Table

Figure 1: Global Genito-Urinary Drugs Historic Market Growth

Figure 2: Global Genito-Urinary Drugs Forecast Market Growth

Figure 3: Genito-Urinary Drugs Market Segmentation

Figure 4: Global Genito-Urinary Drugs Market, 2016, By Segment

Figure 5: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Genito-Urinary Drugs Market, 2016, By Region

Figure 7: Global Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 8: Genito-Urinary Drugs Market, 2016, By Country

Figure 9: Genito-Urinary Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 10: Global Pharmaceutical Market Segments, 2016, By Region

Figure 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 12: Global Pharmaceutical Market Segments, 2016, By Country

Figure 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 14: Genito-Urinary Drugs Market Size, Percentage Of GDP, Global

Figure 15: Per Capita Average Genito-Urinary Drugs Expenditure, Global

Figure 16: Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 17: Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country

Figure 18: Per Capita Average Genito-Urinary Drugs Expenditure, By Country

Figure 19: Global Number Of Pharmacists, 2016, By Country

Figure 20: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 21: Global Number Of Pharma Enterprises, 2016, By Country

Figure 22: Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 23: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 24: Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 26: Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 27: Prevalent Cases Of Contraceptives, 2015, By Country

Figure 28: Global Number Of Obstetricians And Gynaecologists 2016, By Country

Figure 29: Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country

Figure 30: Global Number Of General Practitioners 2016, By Country

Figure 31: Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Figure 32: Asia-Pacific Genito-Urinary Drugs Historic Market, 2012-2016

Figure 33: Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 34: Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment

Figure 35: China Genito-Urinary Drugs Historic Market, 2012-2016

Figure 36: China Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 37: China Genito-Urinary Drugs Market, 2016, By Segment

Figure 38: China Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 39: China Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 40: India Genito-Urinary Drugs Historic Market, 2012-2016

Figure 41: India Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 42: India Genito-Urinary Drugs Market, 2016, By Segment

Figure 43: India Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 44: India Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 45: Japan Genito-Urinary Drugs Historic Market, 2012-2016

Figure 46: Japan Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 47: Japan Genito-Urinary Drugs Market, 2016, By Segment

Figure 48: Japan Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 49: Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 50: Australia Genito-Urinary Drugs Historic Market, 2012-2016

Figure 51: Australia Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 52: Australia Genito-Urinary Drugs Market, 2016, By Segment

Figure 53: Australia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 54: Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 55: Western Europe Genito-Urinary Drugs Historic Market, 2012-2016

Figure 56: Western Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 57: Western Europe Genito-Urinary Drugs Market, 2016, By Segment

Figure 58: UK Genito-Urinary Drugs Historic Market, 2012-2016

Figure 59: UK Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 60: UK Genito-Urinary Drugs Market, 2016, By Segment

Figure 61: UK Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 62: UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 63: Germany Genito-Urinary Drugs Historic Market, 2012-2016

Figure 64: Germany Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 65: Germany Genito-Urinary Drugs Market, 2016, By Segment

Figure 66: Germany Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 67: Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 68: France Genito-Urinary Drugs Historic Market, 2012-2016

Figure 69: France Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 70: France Genito-Urinary Drugs Market, 2016, By Segment

Figure 71: France Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 72: France Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 73: Italy Genito-Urinary Drugs Historic Market, 2012-2016

Figure 74: Italy Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 75: Italy Genito-Urinary Drugs Market, 2016, By Segment

Figure 76: Italy Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 77: Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 78: Spain Genito-Urinary Drugs Historic Market, 2012-2016

Figure 79: Spain Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 80: Spain Genito-Urinary Drugs Market, 2016, By Segment

Figure 81: Spain Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 82: Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 83: Eastern Europe Genito-Urinary Drugs Historic Market, 2012-2016

Figure 84: Eastern Europe Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 85: Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment

Figure 86: Russia Genito-Urinary Drugs Historic Market, 2012-2016

Figure 87: Russia Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 88: Russia Genito-Urinary Drugs Market, 2016, By Segment

Figure 89: Russia Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 90: Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 91: North America Genito-Urinary Drugs Historic Market, 2012-2016

Figure 92: North America Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 93: North America Genito-Urinary Drugs Market, 2016, By Segment

Figure 94: USA Genito-Urinary Drugs Historic Market, 2012-2016

Figure 95: USA Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 96: USA Genito-Urinary Drugs Market, 2016, By Segment

Figure 97: USA Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 98: USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 99: South America Genito-Urinary Drugs Historic Market, 2012-2016

Figure 100: South America Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 101: South America Genito-Urinary Drugs Market, 2016, By Segment

Figure 102: Brazil Genito-Urinary Drugs Historic Market, 2012-2016

Figure 103: Brazil Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 104: Brazil Genito-Urinary Drugs Market, 2016, By Segment

Figure 105: Brazil Genito-Urinary Drugs Percentage Of GDP, 2012-2020

Figure 106: Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012-2020

Figure 107: Middle East Genito-Urinary Drugs Historic Market, 2012-2016

Figure 108: Middle East Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 109: Middle East Genito-Urinary Drugs Market, 2016, By Segment

Figure 110: Africa Genito-Urinary Drugs Historic Market, 2012-2016

Figure 111: Africa Genito-Urinary Drugs Forecast Market, 2016-2020

Figure 112: Africa Genito-Urinary Drugs Market, 2016, By Segment

Figure 113: Pfizer Inc. Financial Performance

Figure 114: Bristol-Myers Squibb Company Financial Performance

Figure 115: F. Hoffmann-La Roche Ltd Financial Performance

Figure 116: Abbott Laboratories Financial Performance

Figure 117: Bayer Ag Financial Performance

Figure 118: Pharmaceutical Drugs Market Historic Growth

Figure 119: Pharmaceutical Drugs Market Forecast Growth

Figure 120: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 121: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 122: Pharmaceutical Drugs Market, 2016, By Country

Figure 123: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 124: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Figure 125: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Figure 126: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 127: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 128: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 129: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 130: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 131: Pharmaceuticals Industry Financial Margins

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Hormonal Contraceptives, Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Harmonal Replacement Therapy, Diuretics


Companies

Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Bayer AG